Book cover for Pharmacology and the Nursing Process

Pharmacology and the Nursing Process

Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder

ISBN #9780323087896

7th Edition

394 Questions

Group icon
2,697 Students Helped

Homework Questions

Right arrow
Summary
Learning Objectives
Key Concepts
Example Problems
Explanations
Common Mistakes

Summary

Chapter 56 on Dermatologic Drugs provides a comprehensive overview of various drug profiles including alpha blockers, beta blockers, MAO-B inhibitors, and alkylating antineoplastic agents, as well as dermatologic and wound care medications. Emphasis is placed on understanding their mechanisms of action, clinical indications, contraindications, adverse effects, pharmacokinetics, and proper administration techniques. This knowledge is crucial for clinicians to choose appropriate therapies, manage drug interactions, and ensure safe and effective patient care.

Learning Objectives

1

Explain the mechanisms of action for dermatologic drugs including alpha blockers, beta blockers, MAO-B inhibitors, alkylating antineoplastic agents, and wound care medications.

2

Identify clinical indications, contraindications, and adverse effects associated with these drug classes.

3

Analyze pharmacokinetic profiles and proper administration methods to optimize therapeutic outcomes.

4

Evaluate potential drug interactions and manage risks to ensure safe patient care in dermatologic therapy.

Key Concepts

CONCEPT

DEFINITION

Alpha Blockers

Medications such as phentolamine and tamsulosin that inhibit alpha-adrenergic receptors, leading to vasodilation and other clinical effects.

Beta Blockers

Drugs that block beta-adrenergic receptors, used not only in cardiovascular conditions but also in certain dermatologic conditions like hemangiomas.

MAO-B Inhibitors

Agents that inhibit the monoamine oxidase B enzyme, affecting neurotransmitter breakdown; used in various neurological and dermatologic contexts with considerations for dietary and drug interactions.

Alkylating Antineoplastic Agents

Cytotoxic drugs that interfere with DNA replication by adding alkyl groups, used in chemotherapy with significant adverse effects and risk management needs.

Dermatologic and Wound Care Medications

A broad category of drugs aimed at treating skin conditions and promoting wound healing, with varying mechanisms and administration routes.

Example Problems

Example 1

The nurse is assessing the skin of a teenage patient who has been using a benzoyl peroxide product for 2 weeks as part of treatment for acne. Which assessment findings indicate that the patient is having an allergic reaction and will need to stop treatment? a Reddened skin over the treatment area b Blistering skin over the treatment area $c$ Peeling skin over the treatment area d Sensation of warmth when the product is applied

Example 2

When considering the variety of OTC topical corticosteroid products, the nurse is aware that which type of preparation is generally most penetrating and effective? a Gel b Lotion c Spray d Ointment

Example 3

The nurse is monitoring for an allergic reaction to topical bacitracin, which would be evident by presence of a petechia. b thickened skin. c itching and burning. d purulent drainage.

Example 4

When the nurse is teaching a patient about the mechanism of action of tretinoin, which statement by the nurse is correct? a "This medication acts by killing the bacteria that cause acne." b "This medication actually causes skin peeling." c "This medication acts by protecting your skin from UV sunlight." d "This medication has antiinflammatory actions."

Example 5

When the nurse is providing wound care with Dakin's solution for a patient who has a stage III pressure ulcer, the patient exclaims, "I smell bleach! Why are you putting bleach on me?" The nurse's best explanation is: a "This is a very dilute solution and acts to reduce the bacteria in the wound so that it can heal." b "This solution is used instead of medication to promote wound healing." c "This solution is used to dissolve the dead tissue in your wound." d "Don't worry; we would never use bleach on a patient!"
Scroll left
Scroll right

Step-by-Step Explanations

QUESTION

How does phentolamine’s mechanism of action contribute to its use in dermatologic applications?

STEP-BY-STEP ANSWER:

Step 1: Recognize that phentolamine blocks alpha-adrenergic receptors, reducing vasoconstriction.
Step 2: Understand that in dermatologic uses, decreased vasoconstriction can improve local blood flow and reduce inflammation.
Step 3: Identify clinical situations such as certain vascular skin lesions where improved perfusion is beneficial.
Final Answer: Phentolamine’s blockade of alpha receptors leads to vasodilation, which can alleviate symptoms and improve blood flow in targeted dermatologic conditions.

Phentolamine (Alpha Blocker)

QUESTION

How does tamsulosin’s receptor selectivity influence its clinical use?

STEP-BY-STEP ANSWER:

Step 1: Identify that tamsulosin selectively blocks alpha-1 receptors, particularly in smooth muscle.
Step 2: Recognize that this selectivity minimizes cardiovascular effects while targeting smooth muscle in specific contexts.
Step 3: Apply this concept to its clinical indications, ensuring appropriate patient selection to manage side effects.
Final Answer: Tamsulosin’s receptor selectivity enables targeted smooth muscle relaxation, making it useful in specific clinical situations where minimized systemic effects are desired.

Tamsulosin (Alpha Blocker)

QUESTION

Describe how beta blockers are used to manage dermatologic conditions, such as hemangiomas.

STEP-BY-STEP ANSWER:

Step 1: Identify that beta blockers function by inhibiting beta-adrenergic receptors, reducing heart rate and blood pressure.
Step 2: Note that in dermatology, beta blockers can reduce the proliferation of vascular tissue in hemangiomas by reducing local adrenergic stimulation.
Step 3: Consider the balance of therapeutic benefits against potential systemic effects and contraindications.
Final Answer: Beta blockers, by dampening adrenergic signaling, can reduce vascular proliferation in conditions like hemangiomas, though careful monitoring for systemic effects is important.

Beta Blockers

QUESTION

What are the important considerations when using MAO-B inhibitors in treatment?

STEP-BY-STEP ANSWER:

Step 1: Understand that MAO-B inhibitors work by blocking the enzyme responsible for breaking down certain neurotransmitters.
Step 2: Recognize that this leads to altered neurotransmitter levels, which can have therapeutic effects as well as risk of interactions with foods and other drugs.
Step 3: Identify common contraindications and the need for dietary restrictions to prevent adverse reactions.
Final Answer: When using MAO-B inhibitors, it is crucial to monitor dietary intake and other medications to prevent dangerous interactions and manage side effects effectively.

MAO-B Inhibitors

QUESTION

How do alkylating agents exert their therapeutic effects, and what are the potential risks?

STEP-BY-STEP ANSWER:

Step 1: Identify that alkylating agents work by introducing alkyl groups into DNA, causing cross-linking and preventing DNA replication.
Step 2: Understand that while effective for cancer treatment, this non-selective action can affect healthy cells, leading to significant adverse effects.
Step 3: Emphasize the need for careful dosing and monitoring to balance efficacy with patient safety.
Final Answer: Alkylating antineoplastic agents disrupt DNA replication through alkylation, a mechanism that underlies their effectiveness in cancer therapy but also poses risks of severe side effects and toxicity.

Alkylating Antineoplastic Agents

Scroll left
Scroll right

Common Mistakes

  • Confusing the specific receptor targets of alpha blockers and beta blockers, leading to inappropriate drug selection.
  • Underestimating the importance of pharmacokinetics and proper dosing, which can result in sub-optimal therapeutic effects or increased toxicity.
  • Overlooking contraindications and potential drug interactions, especially with MAO-B inhibitors and alkylating agents.
  • Failing to educate patients on medication administration and necessary dietary restrictions, increasing the risk of adverse effects.